Skip to main content
Clinical Trials/EUCTR2017-004711-39-FI
EUCTR2017-004711-39-FIActive, not recruitingPhase 1

Tramadol-paracetamol in spine surgery

Merja Kokki0 sites120 target enrollmentStarted: March 9, 2018Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 18-75-year old patient undergoing elective spine surgery
  • BMI 18-35 kg/m2
  • Participants must understand the meaning of the study, and the procedures, and provide informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

Exclusion Criteria

  • Age<18 years or >75 years
  • Hypersensitivity to ibuprofen, other non-steroidal anti-inflammatory drugs, paracetamol, tramadol or their exipients
  • Astma, urticaria or allergic reaction to ASA/NSAIDs
  • Acute bleeding or history if hemorrhage in gastrointestinal tract or peptic ulcer
  • Bleeding disorder
  • Use of nonoamineoxidase inhibitors within last two weeks
  • Severe hepatic impairment.
  • Epilepsy not controlled by treatment
  • Patients susceptible to seizures or taking other medications that lower the seizure threshold
  • Severe liver or renal failure
  • Severe respiratory impairment
  • Severe cardiac insufficiency
  • History or acute intoxication with alcohol, hypnotic medicinal products, centrally-acting analgesics, opioids or psychotropic medicinal products
  • Pregnancy or breastfeeding
  • Other reason investigator estimates prelude participation

Investigators

Sponsor
Merja Kokki

Similar Trials